Bruker (BRKR) Accumulated Expenses (2010 - 2025)

Bruker's Accumulated Expenses history runs 16 years deep, the most recent figure standing at $28.7 million for Q4 2025.

• Quarterly Accumulated Expenses fell 84.72% year-over-year to $28.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28.7 million (down 84.72% YoY) and the FY2025 annual result came in at $28.7 million, down 84.72% from the prior year.
• Accumulated Expenses was $28.7 million for Q4 2025 at Bruker, down from $187.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $187.8 million in Q4 2024 and bottomed at $4.3 million in Q4 2023.
• A 5-year average of $97.8 million and a median of $132.0 million in 2021 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Accumulated Expenses sank 96.84% — and 2024, when it soared 4267.44%.
• Bruker's Accumulated Expenses stood at $132.0 million in 2021, then grew by 3.11% to $136.1 million in 2022, then sank by 96.84% to $4.3 million in 2023, then surged by 4267.44% to $187.8 million in 2024, then slumped by 84.72% to $28.7 million in 2025.
• Business Quant data shows BRKR's Accumulated Expenses at $28.7 million in Q4 2025, $187.8 million in Q4 2024, and $4.3 million in Q4 2023.